In HRD cancers, the JAK-STAT pathway is upregulated in tumor cells, CD4+/CD8+ T cells, and macrophages, implying a common upstream effector in this pathway within HRD cancers. The gene discussed is CD8A; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.